Chondroitin: benefits, dosage, contraindications
Other name(s)
Chondroitin polysulfate
Scientific name(s)
Chondroitin 4-sulfate
Family or group:
Carbohydrates
Active ingredients:
Glucuronic acid
Galactosamine
Indications
Scoring methodology
EFSA approval.
Osteoarthritis ✪✪✪✪✪
Clinical research shows that taking chondroitin sulfate improves the symptoms of osteoarthritis. Indeed, several clinical trials have shown that a daily oral intake of 800 mg to 2000 mg, given as a single or divided dose for at least 3 months, relieves pain and may improve mobility in patients suffering from osteoarthritis. Clinical trials conducted over 2 years show that oral chondroitin sulfate at a dose of 800 mg slows the progression of hip or knee osteoarthritis.
Posologie
Synergies
Comparative Efficacy and Safety Study of Two Chondroitin Sulfate Preparations From Different Origin (Avian and Bovine) in Symptomatic Osteoarthritis of the Knee
Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis
Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis.
Comparison of the Antiinflammatory Efficacy of Chondroitin Sulfate and Diclofenac Sodium in Patients With Knee Osteoarthritis
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens
In a two-year double-blind randomized controlled multicenter study, chondroitin sulfate was significantly superior to celecoxib at reducing cartilage loss with similar efficacy at reducing disease symptoms in knee osteoarthritis patients
Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration
Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review
Dry eye ✪✪✪✪✪
In a double-blind study, the topical application of 1% chondroitin sulfate was found to be as effective as the polyvinyl alcohol artificial tear formulation and 0.1% hyaluronic acid in reducing itching, burning, and foreign body sensation in individuals with keratoconjunctivitis sicca.
Posologie
Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes
The Effects of Sodium Hyaluronate, Chondroitin Sulfate, and Methylcellulose on the Corneal Endothelium and Intraocular Pressure
Psoriasis ✪✪✪✪✪
It has been observed that some patients with psoriasis experience significant clinical and histological improvement of psoriatic lesions after taking chondroitin to treat their osteoarthritis. This effect was confirmed in a clinical trial that suggests chondroitin may offer a particular benefit for patients with both conditions, especially since treatment with anti-inflammatory drugs can induce or exacerbate psoriasis.
Posologie
Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases
Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study
Properties
Vision




Chondroitin has viscoelastic properties that make it useful for ophthalmic applications. Chondroitin sulfate is used as a viscoelastic substance to protect and lubricate cells and tissues during eye surgery, as well as to preserve corneas prior to transplantation. In corneal organ culture in vitro, chondroitin sulfate inhibited the adhesion of Candida albicans.
Usages associés
Bone density




Chondroitin exerts anti-arthritic effects by stimulating the synthesis of proteoglycans (it is a glycoprotein, a combination of a protein and a glycosaminoglycan) and by reducing the catabolic activity of chondrocytes (the cells that make up cartilage). Indeed, it inhibits the synthesis of proteolytic enzymes and has anti-inflammatory activity and effects on osteoblasts in the subchondral bone, with a decrease in bone resorption. Moreover, chondroitin appears to protect cartilage against degradation by inhibiting enzymes in the synovial fluid, such as elastase and hyaluronidase, which damage articular cartilage. It improves the nutrition of chondrocytes by increasing the production of hyaluronic acid in joint cells and therefore the fluid content of the extracellular matrix, which not only acts as a shock absorber but also supplies nutrients to the cartilage.
Usages associés
Anti-inflammatory




Chondroitin exerts an anti-inflammatory action with an inhibitory effect on complement. In an in vitro study of bovine cartilage, chondroitin alone, and in combination with glucosamine, regulates gene expression and the synthesis of nitric oxide and prostaglandin E2, which may explain its anti-inflammatory properties. It has been suggested that the multiple anti-inflammatory effects of chondroitin in chondrocytes and synoviocytes are mainly due to a common mechanism, through inhibition of NF-κB nuclear translocation (a protein involved in the immune response and the cellular stress response). Furthermore, it has also been shown that chondroitin sulfate inhibits the production of prostaglandin E2 and matrix metalloproteinases (a family of enzymes of the peptidase class that have a metal ion in their active site) in osteoblasts, which suggests that the action of chondroitin in osteoarthritis is not only due to effects on cartilage but may also be due to effects on subchondral bone.
Usages associés
Anticancer




In vitro evidence suggests that exogenous chondroitin sulfate regulates the adhesion, motility, and migration of fibrosarcoma cells (a malignant tumor that originates in fibrous connective tissues). There is also evidence that chondroitin may be useful in cancer surveillance. Indeed, the concentration of chondroitin sulfate is increased in the prostatic tissue of men with prostate cancer. There is evidence that measurements of endogenous chondroitin sulfate in the peritumoral stromal tissue of the prostate may be a useful biomarker for disease progression in prostate cancer.
Antiviral




Preliminary research suggests that the chemically oversulfated form of chondroitin is active against HIV, herpes simplex virus, human cytomegalovirus, and dengue virus.
Neurological




In vitro and in vivo evidence suggests that the antioxidant and anti-inflammatory effects of chondroitin contribute to its neuroprotective properties.
Safe dosage
Adult: 800 mg - 2000 mg
Orally, chondroitin sulfate has been used safely at doses up to 2000 mg per day for 6 years. Topical creams can also be used safely.
Interactions
Médicaments
Warfarin: moderate interaction
Taking chondroitin in combination with glucosamine may increase the anticoagulant effects of warfarin (Coumadin) and raise the risk of bruising and bleeding.
Precautions
Pregnancy: avoid
Reliable information available is insufficient to provide guidance on safety during pregnancy.
Breastfeeding: avoid
Avoid use due to lack of reliable and sufficient information.
Asthma: use with caution
There is concern that chondroitin may exacerbate asthma. Asthmatic patients tend to have higher concentrations of anti-chondroitin antibodies in the airways compared with non-asthmatic individuals.
Oral administration
800 - 2000 mg
3 - months
capsule
